BBIO CIK: 1743881

BridgeBio Pharma, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
67.0
FY22:
74.2
FY23:
6.86
FY24:
218
FY25:
481
(positive)
Change from FY21 to FY25
millions USD
FY21:
−577
FY22:
−512
FY23:
−607
FY24:
−593
FY25:
−523
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−485
FY23:
−653
FY24:
−542
FY25:
−733
(positive)
Change from FY21 to FY25
millions USD
FY21:
−563
FY22:
−481
FY23:
−643
FY24:
−536
FY25:
−725

All amounts in millions USD Data source:SEC EDGAR